# HAT in Eye Complications of Behcet's Disease

> **NCT00001865** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 26 (—)

## Conditions studied

- Behcet's Syndrome
- Retinal Disease
- Uveitis

## Interventions

- **DRUG:** Daclizumab

## Key facts

- **NCT ID:** NCT00001865
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 26 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001865, "HAT in Eye Complications of Behcet's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00001865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*